SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 154 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $384,000 | -33.8% | 37,435 | -15.7% | 0.01% | -28.6% |
| Q2 2016 | $580,000 | +23.7% | 44,398 | +4.2% | 0.01% | +16.7% |
| Q1 2016 | $469,000 | +8.6% | 42,614 | -9.2% | 0.01% | +20.0% |
| Q4 2015 | $432,000 | +44.5% | 46,928 | +9.0% | 0.01% | +25.0% |
| Q3 2015 | $299,000 | -33.7% | 43,059 | -6.2% | 0.00% | -33.3% |
| Q2 2015 | $451,000 | 0.0% | 45,890 | -9.8% | 0.01% | +20.0% |
| Q1 2015 | $451,000 | +15.3% | 50,856 | +14.0% | 0.01% | 0.0% |
| Q4 2014 | $391,000 | +21.4% | 44,600 | -4.5% | 0.01% | +25.0% |
| Q3 2014 | $322,000 | +8.8% | 46,682 | -17.0% | 0.00% | 0.0% |
| Q2 2014 | $296,000 | -31.8% | 56,239 | -41.0% | 0.00% | -20.0% |
| Q1 2014 | $434,000 | +214.5% | 95,401 | +248.4% | 0.01% | +150.0% |
| Q4 2013 | $138,000 | -48.9% | 27,381 | -48.6% | 0.00% | -66.7% |
| Q3 2013 | $270,000 | +14.9% | 53,289 | +12.7% | 0.01% | +20.0% |
| Q2 2013 | $235,000 | – | 47,281 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
| GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
| Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
| FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
| MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
| Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
| Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
| GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
| Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
| Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |